Proprietary Heritage

An international centre of excellence

An element that sets EMBL Ventures apart is its strong ties with its funding cornerstone investor, the European Molecular Biology Laboratory (EMBL) and its technology transfer organisation, EMBL Enterprise Management Technology Transfer GmbH (EMBLEM), one of the leading technology transfer organisations in Europe. EMBL is the flagship of European molecular biology and ranks top among the world&rsquo s research institutions. In the past, EMBL has been the source of incredible breakthrough scientific discoveries that have also proven to be commercially extremely attractive.

Discover the non-obvious

Through its ties with EMBL and EMBLEM, EMBL Ventures occupies a privileged position to access promising technologies and products either derived from research at EMBL, the EMBL network, or from selected third parties, before any other investor or interested party. Furthermore, not only does the EMBL network provide the technologies to form new ventures; it also represents an enormous scientific resource that EMBL Ventures can tap into to assess and confirm technological potential from any source, giving the Fund the capacity to recognise the non-obvious that others may overlook.

"I met the people at EMBL Ventures way back prior to our first round of financing. They had a strong scientific as well as entrepreneur background and showed a hands-on approach right from the start. Moreover, they have maintained this spirit over the years: they have never lost interest, have never stopped challenging the management (in a positive way) and have always stayed fully committed to our company."
Dr. Harpreet Singh; Founder & CSO, Immatics Biotechnologies, Tübingen